目次

Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Chlamydia Infections - Overview
Chlamydia Infections - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Chlamydia Infections - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Chlamydia Infections - Companies Involved in Therapeutics Development
Chlamydia Infections - Drug Profiles
Chlamydia Infections - Dormant Projects
Chlamydia Infections - Product Development Milestones
Featured News & Press Releases
Mar 31, 2022: Evofem presents positive encore data in sexually transmitted infections impacting women at the 2022 Academy of Managed Care Pharmacy Annual Meeting
Mar 04, 2022: Evofem completes enrollment in EVOGUARD Phase 3 clinical trial of EVO100 for prevention of chlamydia and gonorrhea in women
Feb 09, 2022: FDA awards QIDP designation for prevention of chlamydia to Evofem Biosciences
Jan 04, 2022: Evofem Biosciences to present at H.C. Wainwright BioConnect Conference
Dec 21, 2021: Eurocine Vaccines resolves on scientific advice with the Swedish Medical Products Agency ahead of clinical trial application
Dec 01, 2021: Eurocine Vaccines Chlamydia vaccine candidate elicits both antibody and T cell responses
Nov 30, 2021: Evofem Biosciences announces successful type C meeting with FDA for STI prevention product candidate
May 17, 2021: New data on EVO100 for the prevention of chlamydia and gonorrhea in women to be presented at ISPOR 2021
Mar 31, 2021: Eurocine Vaccines initiates process development of the vaccine candidate against chlamydia
Mar 16, 2021: Evofem Biosciences announces publication in American Journal of Obstetrics and Gynecology of AMPREVENCE study of EVO100 for chlamydia and gonorrhea prevention
Feb 25, 2021: Eurocine Vaccines confirms good immunological effect in preclinical study with the chlamydia vaccine candidate
Dec 30, 2020: Eurocine Vaccines advances the development of commercial manufacturing method and updates time plan
Dec 30, 2020: Eurocine Vaccines has selected Biovian as contract developer for the chlamydia vaccine candidate
Dec 22, 2020: Evofem Biosciences to participate in Medicaid National Drug Rebate Program for Phexxi effective January 1, 2021
Dec 21, 2020: Evofem Biosciences to present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products under Development for Chlamydia Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Chlamydia Infections - Pipeline by Abera Bioscience AB, 2022
Chlamydia Infections - Pipeline by Abivax SA, 2022
Chlamydia Infections - Pipeline by Aeterna Zentaris Inc, 2022
Chlamydia Infections - Pipeline by BlueWillow Biologics Inc, 2022
Chlamydia Infections - Pipeline by Erganeo, 2022
Chlamydia Infections - Pipeline by Eurocine Vaccines AB, 2022
Chlamydia Infections - Pipeline by Evofem Biosciences Inc, 2022
Chlamydia Infections - Pipeline by Genetic Immunity Inc, 2022
Chlamydia Infections - Pipeline by Lead Discovery Center GmbH, 2022
Chlamydia Infections - Pipeline by Merck & Co Inc, 2022
Chlamydia Infections - Pipeline by Microbiotix Inc, 2022
Chlamydia Infections - Pipeline by QureTech Bio AB, 2022
Chlamydia Infections - Pipeline by Sanofi, 2022
Chlamydia Infections - Pipeline by Traccine Pharmaceuticals, 2022
Chlamydia Infections - Pipeline by Vault Pharma Inc, 2022
Chlamydia Infections - Pipeline by Vaxine Pty Ltd, 2022
Chlamydia Infections - Pipeline by Yaso Therapeutics Inc, 2022
Chlamydia Infections - Dormant Projects, 2022

List of Figures
Number of Products under Development for Chlamydia Infections, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022